ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,686Medicare Part D Prescriptions Filled, Including Refills

Rank: 258 out of 1006

$663K Total Retail Price of All Prescriptions

Rank: 123 out of 1006

362 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 362 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 362 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 6,265 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$99 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 236 206 1 2
AMLODIPINE BESYLATE 216 211 2 4
SIMVASTATIN 207 178 3 1
ATORVASTATIN CALCIUM 177 174 4 5
TAMSULOSIN HCL 155 147 5 23
OMEPRAZOLE 154 130 6 9
METOPROLOL TARTRATE 141 129 7 7
ATENOLOL 134 126 8 13
CRESTOR 131 126 9 18
FUROSEMIDE 121 119 10 6
LISINOPRIL 109 106 11 3
DIOVAN 103 103 12 16
HYDROCHLOROTHIAZIDE 100 96 13 11
TRAMADOL HCL 90 88 14 35
TRAMADOL HCL-ACETAMINOPHEN 88 88 15 133
MELOXICAM 82 79 16 67
ATELVIA 78 75 17 182
ZOLPIDEM TARTRATE 76 73 18 14
BYSTOLIC 73 73 19 84
METOPROLOL SUCCINATE 73 69 19 12
MIRTAZAPINE 72 72 21 26
CARVEDILOL 72 72 21 36
METHYLPREDNISOLONE 70 62 23 148
TRAZODONE HCL 68 61 24 21
NASONEX 66 51 25 176
WARFARIN SODIUM 65 65 26 8
METFORMIN HCL 64 58 27 10
GABAPENTIN 62 60 28 20
AMLODIPINE BESYLATE-BENAZEPRIL 62 58 28 77
BENICAR 60 60 30 78
DOXYCYCLINE HYCLATE 57 54 31 130
PAROXETINE HCL 56 35 32 62
GLIMEPIRIDE 56 49 32 50
ONGLYZA 54 39 34 230
CYMBALTA 52 52 35 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.